327
Pill imprint 327 has been identified as Ticlopidine hydrochloride 250 mg.
Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy.
Ticlopidine 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Ticlopidine hydrochloride Images
- Imprint:
-
327
- Strength:
- 250 mg
- Color:
- Orange
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- 57664-0327
Advertisement
More Ticlopidine Hydrochloride resources
- Ticlopidine (Wolters Kluwer)
- ticlopidine (Cerner Multum)
- ticlopidine (Micromedex) - Includes Dosage Information
- Ticlopidine Hydrochloride (AHFS DI)
- Ticlopidine (FDA)
- Ticlopidine Hydrochloride (Wolters Kluwer)
Search Again
